Actively Recruiting

Age: 18Years +
All Genders
NCT05770349

Ultrastructural Characteristics of Mitochondria in Cardiomyocytes in Heart Failure

Led by Tomsk National Research Medical Center of the Russian Academy of Sciences · Updated on 2026-04-02

45

Participants Needed

1

Research Sites

239 weeks

Total Duration

On this page

Sponsors

T

Tomsk National Research Medical Center of the Russian Academy of Sciences

Lead Sponsor

R

Russian Science Foundation

Collaborating Sponsor

AI-Summary

What this Trial Is About

According to modern concepts, mitochondrial dysfunction may be the fundamental basis for the development and progression of CHF, including in patients undergoing myocardial revascularization. The processes of mitochondrial fusion, division and mitophagy are aimed at maintaining cellular homeostasis. A change in the balance of these processes can lead to the accumulation of damaged organelles with impaired functions. In patients with CHF, dysfunctional mitochondria are characterized by size dispersion, crist disorganization, and localization changes relative to myofibrils. At the same time, the topic of the influence of mitochondrial dysfunction on the prognosis and clinical course of CHF remains debatable today. Direct study of the structural and functional features of mitochondria in human cardiomyocytes is an extremely difficult task, and therefore, such studies are carried out extremely rarely and on very limited cohorts. In the planned study, due to the long time of the study material recruitment, the ultrastructure of mitochondria in a large cohort of patients, ranging from 45 to 60 people, will be studied. The aim of this study is to study the association of mitochondrial dysfunction with the clinical course and outcomes of CHF of ischemic etiology, as well as to assess the degree of compliance of indirect criteria of mitochondrial dysfunction with direct ultrastructural characteristics of mitochondria in cardiomyocytes. This single-center prospective cohort study will involve 45-60 patients. The patients will have biopsy samples taken from the right auricle, as well as blood collection and preservation and its derivatives. Electron microscopy of myocardial samples will be performed to assess the ultrastructure of mitochondria of cardiomyocytes. The results of a direct study of mitochondria will be compared with indirect signs of mitochondrial dysfunction: the registration of the phenomenon of increased leaching of radiopharmaceuticals from the myocardium, an increase in the number of copies of mitochondrial DNA and the concentration of cytochrome C in the blood, the affiliation of mitochondrial DNA to haplogroup K. The results obtained in each of the research tasks will have high scientific significance and publication potential.

CONDITIONS

Official Title

Ultrastructural Characteristics of Mitochondria in Cardiomyocytes in Heart Failure

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of heart failure with reduced or mildly reduced left ventricular ejection fraction (EF <50%)
  • Presence of obstructive multivessel coronary artery disease indicating need for coronary bypass surgery
  • Signed informed consent for participation, biomaterial sampling, and genetic research
Not Eligible

You will not qualify if you...

  • Refusal to undergo revascularization or participate in the study
  • Undergoing additional cardiac surgery beyond coronary bypass (e.g., valve or aneurysm surgery)
  • Active cancer
  • Presence of implanted cardiac devices (EX, AICD, CT)
  • Severe kidney dysfunction (GFR <30 ml/min/1.73 m2)
  • Infiltrative heart diseases such as sarcoidosis, amyloidosis, or storage diseases
  • Autoimmune diseases
  • Acute infections or worsening of chronic somatic diseases
  • Diagnosis of type 1 or type 2 diabetes mellitus
  • Contraindications to myocardial scintigraphy or cardiopulmonary stress testing
  • Inability to receive optimal drug therapy after cardiac surgery

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Tomsk National Research Medical Center, Russian Academy of Sciences

Tomsk, Russia, 634050

Actively Recruiting

Loading map...

Research Team

E

Elena A Kuzheleva, Ph.D.

CONTACT

O

Olga V Tukish, Ph.D.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here